Integrum Investor Relations Material
Latest events
Q3 24/25
Integrum
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Integrum
Access all reports
Integrum AB researches, develops, and sells various systems for bone-anchored prostheses. It specializes in systems for rehabilitation of patients who lose a limb as a result of cancer or a trauma. The company also generates revenues through the sale of spare parts, instruments, implants, and material for bone surgery related to the use of its products. The company offers their products to surgical professionals in selected markets worldwide.
Latest articles
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
Ticker symbol
INTEG
Country
🇸🇪 Sweden